PKC downregulation upon rapamycin treatment attenuates mitochondrial disease

Leigh syndrome is a fatal neurometabolic disorder caused by defects in mitochondrial function. mTOR inhibition with rapamycin attenuates disease progression in a mouse model of Leigh syndrome (Ndufs4 KO mouse); however, the mechanism of rescue is unknown. Here we identify PKC downregulation as a key...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Perez, Miguel, Grillo, Anthony S., Ito, Takashi K., Valente, Anthony S., Han, Jeehae, Entwisle, Samuel W., Huang, Heather Z., Kim, Dayae, Yajima, Masanao, Kaeberlein, Matt, Villén, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017771/
https://www.ncbi.nlm.nih.gov/pubmed/33324011
http://dx.doi.org/10.1038/s42255-020-00319-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017771/
https://www.ncbi.nlm.nih.gov/pubmed/33324011
http://dx.doi.org/10.1038/s42255-020-00319-x

Ejemplares similares